Research in our laboratory focuses on the cellular and molecular mechanisms that regulate neuronal survival and differentiation and the events underlying HIV neuropathology, particularly in the context of drug abuse. We are interested in the roles of chemokines in the CNS and the interaction of chemokine receptors with other major neurotransmitter or neuropeptide receptor systems, such as glutamate and opioid receptors. The long-term goal of our research is to characterize both neuroprotective and deleterious actions of chemokines in the brain and identify therapeutic strategies for treatment of neuroAIDS and other neurological disorders caused by alterations of neuroimmune regulatory mechanisms. Read More

News & Events


Meucci lab publishes review on neuronal dysfunction in HAND

In a new review article published in Cellular and Molecular…

Jared Luchetta awarded neuroAIDS fellowship

Jared Luchetta was appointed as a National Research Service Award…

Meucci lab publishes book chapter on opioid regulation of neuronal iron homeostasis

The Meucci lab published a book chapter on known and potential…

Dr. Meucci contributes to article on links between COVID-19 and Parkinson’s disease

In collaboration with 15 researchers, Dr. Meucci contributed…
phl spines 2

New Meucci lab publication shows that a chemokine can enhance cognitive flexibility

The Meucci lab recently published a new study suggesting…
Bologna 2

DUniBo update: “The Outlooking Scientist”

DUniBo, the new collaboration between Drexel University and the…
Neuronline logo

Morphine releases iron from storage: Research summary on Neuronline

Bradley Nash and Olimpia Meucci recently published an article…
NAI seal

Dr. Meucci elected as a fellow of the National Academy of Inventors

Congratulations to Dr. Meucci, who has been elected as a…